The role of chemotherapy in biliary tract carcinoma

Por Verslype, C., Prenen, H., Van Cutsem, E.
Publicado em 2008

Value of pretreatment MRI determined parameters for predicting outcome after radio-frequency ablation of hepatocellular carcinoma

Por Dresen, R, Michielsen, K, De Keyzer, F, Verslype, C, Topal, B, Aerts, R, Vandecaveye, V
Publicado no Cancer Imaging (2015)

Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts

Por Bulle A, Dekervel J, Deschuttere L, Nittner D, Van Cutsem E, Verslype C, van Pelt J
Publicado em 2020-07-01

Efficacy of the combination of long-acting release octreotide and tamoxifen in patients with advanced hepatocellular carcinoma: a randomised multicentre phase III study

Por Verset, G, Verslype, C, Reynaert, H, Borbath, I, Langlet, P, Vandebroek, A, Peeters, M, Houbiers, G, Francque, S, Arvanitakis, M, Van Laethem, J-L
Publicado em 2007

Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study

Por Kelley, R. K., Verslype, C., Cohn, A. L., Yang, T.-S., Su, W.-C., Burris, H., Braiteh, F., Vogelzang, N., Spira, A., Foster, P., Lee, Y., Van Cutsem, E.
Publicado no Ann Oncol (2017)

The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma

Por Govaere, O, Petz, M, Wouters, J, Vandewynckel, Y-P, Scott, E J, Topal, B, Nevens, F, Verslype, C, Anstee, Q M, Van Vlierberghe, H, Mikulits, W, Roskams, T
Publicado no Oncogene (2017)

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial

Por Verstraete, M, Debucquoy, A, Dekervel, J, van Pelt, J, Verslype, C, Devos, E, Chiritescu, G, Dumon, K, D'Hoore, A, Gevaert, O, Sagaert, X, Van Cutsem, E, Haustermans, K
Publicado no Br J Cancer (2015)